MedTrace Logo

A Cohort Study of Early Onset Neurodegenerative Dementias Prognostic Factors

NCT04254094 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2023-10-06

No results posted yet for this study

Summary

NEODEM is a multicenter cohort study of patients with early-onset degenerative dementia (before age 65), the main objective of which is to study behavioral disorders and in particular depression as functional prognostic factors at 3 years.

Conditions

Interventions

OTHER

Neuropsychological scales

Basic Activity of Daily Living (BADL) and Instrumental Activities of Daily Living (IADL), Neuropsychiatric Inventory (NPI), Cornell Scale for Depression in Dementia (CSDD), Clinical Dementia Rating Scale (CDR) and defining dementia criteria. Also as part of this study, an MRI examination at baseline and at 18 months follow-up will be performed in the Bordeaux center

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Sophie AURIACOMBE, M.D · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-20
Primary Completion
2026-05-20
Completion
2026-05-20

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04254094 on ClinicalTrials.gov